NCT03345420View on ClinicalTrials.gov

Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

December 12, 2017

Primary Completion Date

August 30, 2022

Study Completion Date

June 26, 2025

Conditions

Ductal Breast Carcinoma In SituInvasive Breast CarcinomaStage 0 Breast CancerStage I Breast CancerStage IA Breast CancerStage IB Breast CancerStage II Breast CancerStage IIA Breast CancerStage IIB Breast Cancer

Interventions

RADIATION

Hypofractionated Radiation Therapy

Undergo hypofractionated radiation therapy

Trial Locations (1)

84112

Huntsman Cancer Institute/University of Utah, Salt Lake City

All Listed Sponsors

lead

University of Utah

OTHER

NCT03345420 - Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer | Biotech Hunter | Biotech Hunter